NIH-funded research R01 grant

Bioengineered lymphatic healing platform for breast cancer-related lymphedema

Official title: Bioengineered lymphatic regenerating platform for treatment of breast cancer related lymphedema

Funded at Rice University · NIH-11359627 · Data updated 2026-11-12

A new brainy hydrogel-based approach aims to help people who develop lymphedema after breast cancer by guiding and regenerating lymphatic vessels.

More Breast Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRice University
NIH-funded
Lab location1 site (Houston, United States)
Project startJune 20, 2025
Project endApril 30, 2029
Funding year2026
Award (this year)$460,788
NIH project number5R01HL179534-02
Project IDNIH-11359627 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with breast cancer-related lymphedema who are candidates for future regenerative therapies.

Less likely to help

People whose lymphedema is unrelated to breast cancer, or who have conditions that prevent lymphatic regeneration.

What this research studies

This project uses a 3D-printable alginate hydrogel layer, coated with an anti-fibrotic molecule, to recruit and reconstruct lymphatic vessels in affected regions. It combines programmable cell therapies within the hydrogel to promote lymphatic growth while reducing foreign-body reactions. The goal is to address the root causes of lymphedema instead of relying on lifelong compression, potentially lowering infection and hospitalization risks. The work is tested in preclinical models and focuses on translating these findings toward human treatment options.

Why it matters

Potential benefit: If successful, the platform could reduce or reverse breast cancer-related lymphedema, improving swelling, infections, and quality of life.

How similar studies have gone: Previous work shows promise in guiding lymphatic growth with hydrogels, but challenges remain in avoiding immune reactions and achieving durable regeneration.

Where this research is happening

  • Rice University
    Houston, United States
    Active

Researchers

  • Principal investigator: Veiseh, Omid — Rice University
  • Study coordinator: Veiseh, Omid

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.